The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animals Cell Viability Assays-Global Market Insights and Sales Trends 2024
Synopsis
The global Animals Cell Viability Assays market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animals Cell Viability Assays in various end use industries. The expanding demands from the Stem Cell Research, Clinical and Diagnostic Applications, Drug Discovery and Development and Other, are propelling Animals Cell Viability Assays market. Test Kit, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Counter segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 271%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animals Cell Viability Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animals Cell Viability Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animals Cell Viability Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animals Cell Viability Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animals Cell Viability Assays covered in this report include Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson＆Company, Promega Corporation, Biotium and Abcam plc, etc.
The global Animals Cell Viability Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories
GE Healthcare
Danaher Corporation
Becton Dickinson＆Company
Promega Corporation
Biotium
Abcam plc
Creative Bioarray
Biotek Instruments
PerkinElmer
Global Animals Cell Viability Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animals Cell Viability Assays market, Segment by Type:
Test Kit
Cell Counter
Cytometer
Cell Imaging and Analysis System
Other
Global Animals Cell Viability Assays market, by Application
Stem Cell Research
Clinical and Diagnostic Applications
Drug Discovery and Development
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animals Cell Viability Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Animals Cell Viability Assays market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animals Cell Viability Assays in various end use industries. The expanding demands from the Stem Cell Research, Clinical and Diagnostic Applications, Drug Discovery and Development and Other, are propelling Animals Cell Viability Assays market. Test Kit, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Counter segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 271%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animals Cell Viability Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animals Cell Viability Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animals Cell Viability Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animals Cell Viability Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animals Cell Viability Assays covered in this report include Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson＆Company, Promega Corporation, Biotium and Abcam plc, etc.
The global Animals Cell Viability Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories
GE Healthcare
Danaher Corporation
Becton Dickinson＆Company
Promega Corporation
Biotium
Abcam plc
Creative Bioarray
Biotek Instruments
PerkinElmer
Global Animals Cell Viability Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animals Cell Viability Assays market, Segment by Type:
Test Kit
Cell Counter
Cytometer
Cell Imaging and Analysis System
Other
Global Animals Cell Viability Assays market, by Application
Stem Cell Research
Clinical and Diagnostic Applications
Drug Discovery and Development
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animals Cell Viability Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Animals Cell Viability Assays
1.1 Animals Cell Viability Assays Market Overview
1.1.1 Animals Cell Viability Assays Product Scope
1.1.2 Animals Cell Viability Assays Market Status and Outlook
1.2 Global Animals Cell Viability Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Animals Cell Viability Assays Market Size by Region (2018-2029)
1.4 Global Animals Cell Viability Assays Historic Market Size by Region (2018-2023)
1.5 Global Animals Cell Viability Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Animals Cell Viability Assays Market Size (2018-2029)
1.6.1 North America Animals Cell Viability Assays Market Size (2018-2029)
1.6.2 Europe Animals Cell Viability Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Animals Cell Viability Assays Market Size (2018-2029)
1.6.4 Latin America Animals Cell Viability Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Animals Cell Viability Assays Market Size (2018-2029)
2 Animals Cell Viability Assays Market by Type
2.1 Introduction
2.1.1 Test Kit
2.1.2 Cell Counter
2.1.3 Cytometer
2.1.4 Cell Imaging and Analysis System
2.1.5 Other
2.2 Global Animals Cell Viability Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Animals Cell Viability Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Animals Cell Viability Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Animals Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Animals Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Animals Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Animals Cell Viability Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Animals Cell Viability Assays Revenue Breakdown by Type (2018-2029)
3 Animals Cell Viability Assays Market Overview by Application
3.1 Introduction
3.1.1 Stem Cell Research
3.1.2 Clinical and Diagnostic Applications
3.1.3 Drug Discovery and Development
3.1.4 Other
3.2 Global Animals Cell Viability Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Animals Cell Viability Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Animals Cell Viability Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Animals Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Animals Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Animals Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Animals Cell Viability Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Animals Cell Viability Assays Revenue Breakdown by Application (2018-2029)
4 Animals Cell Viability Assays Competition Analysis by Players
4.1 Global Animals Cell Viability Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animals Cell Viability Assays as of 2022)
4.3 Date of Key Players Enter into Animals Cell Viability Assays Market
4.4 Global Top Players Animals Cell Viability Assays Headquarters and Area Served
4.5 Key Players Animals Cell Viability Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Animals Cell Viability Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific Inc.
5.1.1 Thermo Fisher Scientific Inc. Profile
5.1.2 Thermo Fisher Scientific Inc. Main Business
5.1.3 Thermo Fisher Scientific Inc. Animals Cell Viability Assays Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Inc. Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Inc. Recent Developments
5.2 Merck KGaA
5.2.1 Merck KGaA Profile
5.2.2 Merck KGaA Main Business
5.2.3 Merck KGaA Animals Cell Viability Assays Products, Services and Solutions
5.2.4 Merck KGaA Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Merck KGaA Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories Animals Cell Viability Assays Products, Services and Solutions
5.3.4 Bio-Rad Laboratories Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.3.5 GE Healthcare Recent Developments
5.4 GE Healthcare
5.4.1 GE Healthcare Profile
5.4.2 GE Healthcare Main Business
5.4.3 GE Healthcare Animals Cell Viability Assays Products, Services and Solutions
5.4.4 GE Healthcare Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.4.5 GE Healthcare Recent Developments
5.5 Danaher Corporation
5.5.1 Danaher Corporation Profile
5.5.2 Danaher Corporation Main Business
5.5.3 Danaher Corporation Animals Cell Viability Assays Products, Services and Solutions
5.5.4 Danaher Corporation Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Corporation Recent Developments
5.6 Becton Dickinson＆Company
5.6.1 Becton Dickinson＆Company Profile
5.6.2 Becton Dickinson＆Company Main Business
5.6.3 Becton Dickinson＆Company Animals Cell Viability Assays Products, Services and Solutions
5.6.4 Becton Dickinson＆Company Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Becton Dickinson＆Company Recent Developments
5.7 Promega Corporation
5.7.1 Promega Corporation Profile
5.7.2 Promega Corporation Main Business
5.7.3 Promega Corporation Animals Cell Viability Assays Products, Services and Solutions
5.7.4 Promega Corporation Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Promega Corporation Recent Developments
5.8 Biotium
5.8.1 Biotium Profile
5.8.2 Biotium Main Business
5.8.3 Biotium Animals Cell Viability Assays Products, Services and Solutions
5.8.4 Biotium Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Biotium Recent Developments
5.9 Abcam plc
5.9.1 Abcam plc Profile
5.9.2 Abcam plc Main Business
5.9.3 Abcam plc Animals Cell Viability Assays Products, Services and Solutions
5.9.4 Abcam plc Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Abcam plc Recent Developments
5.10 Creative Bioarray
5.10.1 Creative Bioarray Profile
5.10.2 Creative Bioarray Main Business
5.10.3 Creative Bioarray Animals Cell Viability Assays Products, Services and Solutions
5.10.4 Creative Bioarray Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Creative Bioarray Recent Developments
5.11 Biotek Instruments
5.11.1 Biotek Instruments Profile
5.11.2 Biotek Instruments Main Business
5.11.3 Biotek Instruments Animals Cell Viability Assays Products, Services and Solutions
5.11.4 Biotek Instruments Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Biotek Instruments Recent Developments
5.12 PerkinElmer
5.12.1 PerkinElmer Profile
5.12.2 PerkinElmer Main Business
5.12.3 PerkinElmer Animals Cell Viability Assays Products, Services and Solutions
5.12.4 PerkinElmer Animals Cell Viability Assays Revenue (US$ Million) & (2018-2023)
5.12.5 PerkinElmer Recent Developments
6 North America
6.1 North America Animals Cell Viability Assays Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Animals Cell Viability Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animals Cell Viability Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animals Cell Viability Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animals Cell Viability Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animals Cell Viability Assays Market Dynamics
11.1 Animals Cell Viability Assays Industry Trends
11.2 Animals Cell Viability Assays Market Drivers
11.3 Animals Cell Viability Assays Market Challenges
11.4 Animals Cell Viability Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
